We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
FluoroPharma Medical Inc (CE) | USOTC:FPMI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
333-151381 | 20-8325616 | |
(Commission File Number) | (IRS Employer Identification No.) |
·
|
the failure to pay principal within ten business days after such amounts are due;
|
·
|
the Company breaches any material covenant or other term or condition of the Notes, the Purchase Agreement or other transaction document, except for a breach of payment, in any material respect and such breach, if subject to cure, continues for a period of twenty days after written notice to the Company from the investor;
|
·
|
the Company is advised by written notice from the investor that a material representation or warranty of the Company made in the Notes or Purchase Agreement was false or misleading in any material respect;
|
·
|
any dissolution, liquidation or winding up by the Company or a subsidiary of a substantial portion of their business;
|
·
|
any cessation of operations by the Company or a subsidiary;
|
·
|
the failure by the Company or any subsidiary to maintain any material intellectual property rights, personal, real property, equipment, leases or other assets which are necessary to conduct its business (whether now or in the future) and such breach is not cured with thirty days after written notice to such effect;
|
·
|
any money judgment shall be entered or made in a non-appealable adjudication against the Company or any subsidiary or any of their properties or other assets for more than $250,000 in excess of the Company’s insurance coverage, unless stayed vacated or satisfied within 60 days;
|
·
|
the Company files any petition or action for relief under any bankruptcy or makes any assignment for the benefit of creditors; or
|
·
|
an involuntary petition is filed against the Company under any bankruptcy statute now or hereafter in effect, and such petition is not dismissed or discharged within 60 days.
|
Exhibit No.
|
Description
|
|
4.1
|
Form of Note.
|
|
10.1
|
Form of Note Purchase Agreement.
|
|
10.2
|
Form of Registration Rights Agreement.
|
Dated: March 23, 2016
|
|
FLUOROPHARMA MEDICAL, INC.
By:
/s/ Thomas H. Tulip
Name Thomas H. Tulip
Title: President and CEO
|
1 Year FluoroPharma Medical (CE) Chart |
1 Month FluoroPharma Medical (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions